These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 10459118)
1. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. Bergasa NV; Alling DW; Talbot TL; Wells MC; Jones EA J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):431-4. PubMed ID: 10459118 [TBL] [Abstract][Full Text] [Related]
2. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. Terg R; Coronel E; Sordá J; Muñoz AE; Findor J J Hepatol; 2002 Dec; 37(6):717-22. PubMed ID: 12445410 [TBL] [Abstract][Full Text] [Related]
4. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521 [TBL] [Abstract][Full Text] [Related]
5. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. Jones EA; Neuberger J; Bergasa NV QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394 [TBL] [Abstract][Full Text] [Related]
6. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Bergasa NV; Alling DW; Talbot TL; Swain MG; Yurdaydin C; Turner ML; Schmitt JM; Walker EC; Jones EA Ann Intern Med; 1995 Aug; 123(3):161-7. PubMed ID: 7598296 [TBL] [Abstract][Full Text] [Related]
7. A controlled trial of ondansetron in the pruritus of cholestasis. O'Donohue JW; Pereira SP; Ashdown AC; Haigh CG; Wilkinson JR; Williams R Aliment Pharmacol Ther; 2005 Apr; 21(8):1041-5. PubMed ID: 15813840 [TBL] [Abstract][Full Text] [Related]
8. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Jones EA; Dekker LR Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471 [TBL] [Abstract][Full Text] [Related]
9. Ondansetron and pruritus in chronic liver disease: a controlled study. Jones EA; Molenaar HA; Oosting J Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis. Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814 [TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy. Neuberger J; Jones EA Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Mason BJ; Ritvo EC; Morgan RO; Salvato FR; Goldberg G; Welch B; Mantero-Atienza E Alcohol Clin Exp Res; 1994 Oct; 18(5):1162-7. PubMed ID: 7847600 [TBL] [Abstract][Full Text] [Related]
14. Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. Bergasa NV; McGee M; Ginsburg IH; Engler D Hepatology; 2006 Nov; 44(5):1317-23. PubMed ID: 17058231 [TBL] [Abstract][Full Text] [Related]
15. The effects of nalmefene, a potent oral opiate antagonist, on exercise-induced bronchospasm. Christopher MA; Wyzan D; Harman E; Hendeles L J Allergy Clin Immunol; 1988 Dec; 82(6):1037-41. PubMed ID: 3204249 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. Metze D; Reimann S; Beissert S; Luger T J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Bergasa NV; Talbot TL; Alling DW; Schmitt JM; Walker EC; Baker BL; Korenman JC; Park Y; Hoofnagle JH; Jones EA Gastroenterology; 1992 Feb; 102(2):544-9. PubMed ID: 1732125 [TBL] [Abstract][Full Text] [Related]
18. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Terra SG; Tsunoda SM Ann Pharmacother; 1998 Nov; 32(11):1228-30. PubMed ID: 9825091 [TBL] [Abstract][Full Text] [Related]
19. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease. Kumar N; Garg N; Bailey A J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399 [No Abstract] [Full Text] [Related]
20. Prolonged blockade of opioid effect with oral nalmefene. Gal TJ; DiFazio CA; Dixon R Clin Pharmacol Ther; 1986 Nov; 40(5):537-42. PubMed ID: 3533370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]